Login / Signup

Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study.

Emily A BlumbergGary CollinsJo-Anne H YoungM Hong NguyenDavid MichonneauZelelem TemesgenJulia OrigȕenLaura BarcanKaram M ObeidWaldo H BellosoJulien GrasGiulio Maria CorbelliJames D NeatonJens Dilling LundgrenDavid R SnydmanJean-Michel Molinanull null
Published in: Transplant infectious disease : an official journal of the Transplantation Society (2021)
Among adults who develop CDI after SOT or HSCT, despite their immunosuppressed state, the percentage with clinical cure was high and the percentage with recurrence was low. Clinical cure and recurrence varied by type of initial treatment, and CMV viremia/disease was associated with an increased risk of recurrence. This article is protected by copyright. All rights reserved.
Keyphrases
  • hematopoietic stem cell
  • free survival
  • clostridium difficile
  • replacement therapy